14 · Verified Catalyst Calendar

Verified Catalyst Calendar

Erasca says 44% of 25 responded; it’s Phase 1 · No. 052 · · About 3 min read

Bookmarks need a Mind Club sign-in. How sign-in works

Verified Catalyst Calendar across your briefs

Two goal dates this weekend, BBP-418 the day after Thanksgiving and a busy 11.30, then the FOMC, ASH and a run of December goal dates. Eighteen of 22 dates are confirmed at a company, agency or organizer source.

DateEventWhoConfirmed at
Sun 11.22Goal date, molgramostim in autoimmune pulmonary alveolar proteinosis, extended after a major amendmentSavaraAggregator
Sun 11.22Goal date, deramiocel in Duchenne muscular dystrophy, extended from 08.22 after a major amendmentCapricorCompany
Fri 11.27Goal date, BBP-418 in limb-girdle muscular dystrophy 2I/R9, priority reviewBridgeBioCompany
Mon 11.30Goal date, giredestrant as adjuvant therapy in early breast cancer (lidERA), priority reviewRocheCompany
Mon 11.30Goal date, povetacicept in IgA nephropathy, accelerated approvalVertexCompany
Mon 11.30Goal date, bezuclastinib with sunitinib in GISTCogentCompany
Mon 11.30Deadline for CMS to publish any 2028 negotiated or renegotiated pricesCMSGov
Wed 12.02PIVOT-006 presentation at SUOCG OncologyPress
Thu 12.03Goal date, zanzalintinib with atezolizumab in previously treated metastatic colorectal cancerExelixisCompany
Mon 12.07ASH late-breaking abstracts posted, 9:00 am ETASHOrganizer
Tue 12.08 to Wed 12.09FOMC meeting, with projections; rate decision 12.09Federal ReserveGov
Sat 12.12Goal date, imsidolimab in generalized pustular psoriasisVandaPress
Sat 12.12 to Tue 12.15ASH Annual Meeting, New OrleansASHOrganizer
Sat 12.12Anito-cel orals at ASH: iMMagine-1 update and newly diagnosed myelomaGileadCompany
Fri 12.18Goal date, CAM2029 (octreotide depot) in acromegaly, after resubmissionCamurusCompany
Sat 12.19Goal date, imlifidase for kidney transplant desensitizationHansa BiopharmaCompany
Tue 12.22Goal date, lorundrostat in hypertensionMineralysCompany
Wed 12.23Goal date, anito-cel in relapsed or refractory multiple myelomaGileadCompany
Sun 12.27Goal date, relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathiesPraxisCompany
Sun 12.27Goal date, fast-acting meloxicam (MR-107A-02) in acute painViatrisAggregator
Wed 12.30Goal date, bezuclastinib in nonadvanced systemic mastocytosisCogentCompany
Wed 12.30Goal date, SL1009 (sodium dichloroacetate) in pyruvate dehydrogenase complex deficiency, after resubmissionSaol TherapeuticsCompany

Confirmed today: Capricor 8-K (08.24) (opens another website in a new tab); BridgeBio third quarter report (10.29) (opens another website in a new tab); Vertex (06.01) (opens another website in a new tab); Cogent (11.05) (opens another website in a new tab); Gilead (11.04) (opens another website in a new tab); Praxis (11.09) (opens another website in a new tab) Co; Federal Reserve FOMC calendar (opens another website in a new tab) Gov; Savara via Panabee (opens another website in a new tab) and Viatris via a PR Newswire roundup (opens another website in a new tab) Data. CMS IPAY 2028 guidance fact sheet (opens another website in a new tab) Gov. Carried from the 11.19 edition, not reopened today: Roche, SUO, Exelixis, ASH, Vanda, Camurus, Hansa Biopharma, Mineralys and Saol. Calendar dates can move without notice.